Osteoarthritis

Personalized Risk Model and Leveraging of Magnetic Resonance Imaging–Based Structural Phenotypes and Clinical Factors to Predict Incidence of Radiographic Osteoarthritis

Arthritis Care Res (Hoboken)Published Retrospective cohort study

Main finding · Time to radiographic OA (radiographic OA disease-free survival), adjusted for risk factorsResult — go to the resultTimes higher risk 2.8 95% CI 2.25–7.54

Authors' conclusion

Four ROAMES phenotypes may contribute to time to radiographic OA incidence

Study context

Population
Participants without radiographic osteoarthritis (OA) at baseline from the Osteoarthritis Initiative study
Participants
2,328 participants
Exposure
Magnetic resonance imaging (MRI)-based Rapid Osteoarthritis MRI Eligibility Score (ROAMES) structural phenotypes present vs absent
Outcome
Time to incidence of radiographic OA (radiographic OA disease-free survival)
Methodological detailsdeep-learning MRI phenotype assessment, Cox proportional hazards regression, adjusted for known risk factors
  • Deep-learning MRI phenotype assessment
  • Cox proportional hazards regression
  • Adjusted for known risk factors

Main finding

As reported in the abstract

Time to radiographic OA (radiographic OA disease-free survival), adjusted for risk factors

Times higher risk

2.8

95% CI 2.25–7.54

Observational data: associations, not effects.

Further findings

OutcomeTimes higher risk (95% CI)
Radiographic OA risk: female with hypertrophic phenotype vs male without hypertrophic phenotype2.8 (2.25–7.54)

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Personalized Risk Model and Leveraging of Magnetic Resonance Imaging–Based Structural Phenotypes and Clinical Factors to Predict Incidence of Radiographic Osteoarthritis. Arthritis Care Res (Hoboken). Published 10 December 2022. doi:10.1002/acr.24877

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.